Evidence map›Paper›PMID 33037935›Full record

ReviewCurrent cardiology reports2020

Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease.

Benjamin Kelly, Sheyanth Mohanakumar, Vibeke Elisabeth Hjortdal

Open access · hybridAbstract readReview
In one paragraph

Review in Current cardiology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Octreotide improves human lymphatic fluid transport a translational trial.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2024
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Lymphangiogenesis: A new strategy for heart disease treatment (Review).International journal of molecular medicine · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Role of Lymphangiogenesis in Cardiac Repair and Regeneration.Methodist DeBakey cardiovascular journal · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Benjamin KellyDepartment of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark. Benjaminkelly@clin.au.dk.ORCID 0000-0001-7472-4237
Sheyanth MohanakumarDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Vibeke Elisabeth HjortdalDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Aarhus University · DK

Funding

Novo Nordisk Fonden NNF17OC0029854Sundhedsvidenskabelige Fakultet, Aarhus Universitet PhD Stipend
6 · The paper itself

Abstract

purpose of reviewLymphatic disorders have received an increasing amount of attention over the last decade. Sparked primarily by improved imaging modalities and the dawn of lymphatic interventions, understanding, diagnostics, and treatment of lymphatic complications have undergone considerable improvements. Thus, the current review aims to summarize understanding, diagnostics, and treatment of lymphatic complications in individuals with congenital heart disease. RECENT

findingsThe altered hemodynamics of individuals with congenital heart disease has been found to profoundly affect morphology and function of the lymphatic system, rendering this population especially prone to the development of lymphatic complications such as chylous and serous effusions, protein-losing enteropathy and plastic bronchitis. Although improved, a full understanding of the pathophysiology and targeted treatment for lymphatic complications is still wanting. Future research into pharmacological improvement of lymphatic function and continued implementation of lymphatic imaging and interventions may improve knowledge, treatment options, and outcome for affected individuals.

Indexed as

BronchitisHeart Defects, CongenitalLymphatic DiseasesProtein-Losing EnteropathiesHemodynamicsHumansChylothoraxCongenital heart diseaseLymphatic complicationsPlastic bronchitisProlonged effusionProtein-losing enteropathy

Identifiers

PMID33037935
PMCPMC7547563
OpenAlexW3092014039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.